Search

Search Constraints

You searched for: Author/Creator Boxer, Adam L.

Search Results

1. 18F‐flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study. Issue 4 (23rd October 2017)

2. 18F‐fluorodeoxyglucose‐positron emission tomography Findings in Patients with Genetic Frontotemporal Dementia. (20th December 2022)

3. [18F]Flortaucipir PET to autopsy pathology comparisons in Alzheimer's disease and other neurodegenerative diseases: Biomarkers: Leveraging postmortem collections to validate neuroimaging. (7th December 2020)

4. [18F]PI‐2620 PET in four‐repeat tauopathies: a preliminary study. (20th December 2022)

5. [O2–17–01]: RESULTS OF A PHASE 1, SINGLE ASCENDING DOSE, PLACEBO‐CONTROLLED STUDY OF ABBV‐8E12 IN PATIENTS WITH PROGRESSIVE SUPRANUCLEAR PALSY AND PHASE 2 STUDY DESIGN IN EARLY ALZHEIMER's DISEASE. (1st July 2017)

6. [O3–03–04]: AV1451‐PET UPTAKE AND CSF BIOMARKERS IN A HETEROGENEOUS CLINICAL SAMPLE: TWO SIDES OF THE SAME COIN?. (1st July 2017)

7. [O4–02–02]: POLY‐GP DIPEPTIDE REPEATS AND NEUROFILAMENT LIGHT CHAIN AS BIOMARKERS IN PRESYMPTOMATIC AND SYMPTOMATIC FRONTOTEMPORAL DEMENTIA CAUSED BY C9ORF72 REPEAT EXPANSIONS. (1st July 2017)

8. [P1–254]: CHARACTERISTICS AND PROGRESS ON THE INITIAL 209 SUBJECTS IN THE LONGITUDINAL EVALUATION OF FAMILIAL FRONTOTEMPORAL DEMENTIA SUBJECTS (LEFFTDS) PROTOCOL. (1st July 2017)

9. [P1–317]: QUALITY OF LIFE AMONG SUBJECTS AND INFORMANTS IN FAMILIAL FRONTOTEMPORAL DEMENTIA: PRELIMINARY DATA IN THE LEFFTDS COHORT. (1st July 2017)

10. [P2–281]: CAREGIVER BURDEN IN FAMILIAL FRONTOTEMPORAL DEMENTIA SUBJECTS: PRELIMINARY DATA IN THE LEFFTDS COHORT. (1st July 2017)